Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
43,213,381
-
Share change
-
+10,256,759
-
Total reported value
-
$14,678,973
-
Put/Call ratio
-
21%
-
Price per share
-
$0.34
-
Number of holders
-
56
-
Value change
-
+$3,302,319
-
Number of buys
-
23
-
Number of sells
-
23
Institutional Holders of LEAP THERAPEUTICS INC - COM (LPTX) as of Q1 2023
As of 31 Mar 2023,
LEAP THERAPEUTICS INC - COM (LPTX) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,213,381 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Artal Group S.A., VANGUARD GROUP INC, 683 Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, Key Client Fiduciary Advisors, LLC, and Cormorant Asset Management, LP.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.